Rubocom Project Inc (RUBI) Drops 6.84% on February 08

Equities Staff |

Rubocom Project Inc (RUBI) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 6.84% to $12.25, a loss of $-0.9 per share. Starting at an opening price of $12.78 a share, the stock traded between $12.13 and $12.84 over the course of the trading day. Volume was 314,987 shares over 2,267 trades, against an average daily volume of 400,925 shares and a total float of 44.38 million.

The losses send Rubocom Project Inc down to a market cap of $543.64 million. In the last year, Rubocom Project Inc has traded between $20.59 and $13.08, and its 50-day SMA is currently $15.03 and 200-day SMA is $15.69.

The Rubicon Project Inc is a company that automates the buying & selling of advertising. Its Advertising Automation Cloud is a platform providing user reach & a marketplace for the real time trading of digital advertising between buyers & sellers.

Rubocom Project Inc is based out of Los Angeles, CA and has some 470 employees. Its CEO is Frank Addante.

For a complete fundamental analysis analysis of Rubocom Project Inc, check out Equities.com’s Stock Valuation Analysis report for RUBI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.